Menggang Yu

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

Biometrics

Developmental medicine and child neurology

JCO precision oncology

Journal of medical Internet research

University of Wisconsin

University of Michigan (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Wisconsin Jan 01 2012

United States

Professor :: Biostatistics and Medical Informatics

Education History

University of Michigan Sep 01 1999 - Dec 01 2003

United States

PHD :: Biostatistics

Publications

Yi Chen, Menggang Yu
Randomized phase II selection design with order constrained strata. Biometrics 80 (1) (2024)
Yi Chen, Menggang Yu
Randomized phase II selection design with order constrained strata. Biometrics 80 (1) (2024)
Yi Chen, Menggang Yu
Randomized phase II selection design with order constrained strata. Biometrics 80 (1) (2024)
Rui Chen, Guanhua Chen, Menggang Yu
Entropy balancing for causal generalization with target sample summary information. Biometrics (2023)
Deborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, Sumati V Gupta, Ulka N Vaishampayan, Elisabeth I Heath, Philip Garcia, Qianqian Zhao, Menggang Yu, Matthew I Milowsky, Matthew D Galsky
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations. JCO precision oncology 7 (2023)
Kourtney L Kostecki, Mari Iida, Anne L Wiley, Stanley Kimani, Bridget Mehall, Kaitlin Tetreault, Roxana Alexandridis, Menggang Yu, Seungpyo Hong, Ravi Salgia, Justine Yang Bruce, Raymond B Birge, Paul M Harari, Deric L Wheeler
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer. Head & neck (2023)
Muxuan Liang, Menggang Yu
Relative contrast estimation and inference for treatment recommendation. Biometrics (2023)
Muxuan Liang, Menggang Yu
Relative contrast estimation and inference for treatment recommendation. Biometrics (2023)
Maureen A Smith, Menggang Yu, Jared D Huling, Xinyi Wang, Allie DeLonay, Jonathan Jaffery
Impactability Modeling for Reducing Medicare Accountable Care Organization Payments and Hospital Events in High-Need High-Cost Patients: Longitudinal Cohort Study. Journal of medical Internet research 24 (6) (2022)
Margaret B Nolan, Thomas M Piasecki, Stevens S Smith, Timothy B Baker, Michael C Fiore, Robert T Adsit, Daniel M Bolt, Karen L Conner, Steven L Bernstein, Oliver S Eng, David Lazuk, Alec Gonzalez, Todd Hayes-Birchler, Douglas E Jorenby, Heather D'Angelo, Julie A Kirsch, Brian S Williams, Sean Kent, Hanna Kim, Stanley A Lubanski, Menggang Yu, Youmi Suk, Yuxin Cai, Nitu Kashyap, Jomol Mathew, Gabriel McMahan, Betsy Rolland, Hilary A Tindle, Graham W Warren, Noor Abu-El-Rub, Lawrence C An, Andrew Dallas Boyd, Darlene H Brunzell, Victor A Carrillo, Li-Shiun Chen, James M Davis, Vikrant G Deshmukh, Deepika Dilip, Adam O Goldstein, Patrick K Ha, Eduardo Iturrate, Thulasee Jose, Niharika Khanna, Andrea C King, Elizabeth Klass, Michelle Lui, Robin J Mermelstein, Chester Poon, Elisa K Tong, Karen M Wilson, Wendy E Theobald, Wendy S Slutske
Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)
Matthew L Bootsma, Rana R McKay, Hamid Emamekhoo, Rory M Bade, Jennifer L Schehr, Matthew C Mannino, Anupama Singh, Serena K Wolfe, Zachery D Schultz, Jamie M Sperger, Wanling Xie, Sabina Signoretti, Christos E Kyriakopoulos, David Kosoff, Edwin J Abel, Kyle T Helzer, Nicholas Rydzewski, Hamza Bakhtiar, Yue Shi, Grace Blitzer, Michael Bassetti, John M Floberg, Menggang Yu, Nan Sethakorn, Marina N Sharifi, Paul M Harari, Toni K Choueiri, Joshua M Lang, Shuang G Zhao
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (31) (2022)
Jessica R Schumacher, Heather B Neuman, Menggang Yu, David J Vanness, Yajuan Si, Elizabeth S Burnside, Kathryn J Ruddy, Ann H Partridge, Deborah Schrag, Stephen B Edge, Ying Zhang, Elizabeth A Jacobs, Jeffrey Havlena, Amanda B Francescatti, David P Winchester, Daniel P McKellar, Patricia A Spears, Benjamin D Kozower, George J Chang, Caprice C Greenberg, null null
Surveillance Imaging vs Symptomatic Recurrence Detection and Survival in Stage II-III Breast Cancer (AFT-01). Journal of the National Cancer Institute 114 (10) (2022)
Jared D Huling, Menggang Yu
Sufficient dimension reduction for populations with structured heterogeneity. Biometrics (2021)
Menggang Yu, Ryan J Coller, Amy J Kind
Tailored interventions to reduce hospital admissions for individuals with cerebral palsy. Developmental medicine and child neurology 62 (8) (2020)
Rui Chen, Menggang Yu
Tailored optimal posttreatment surveillance for cancer recurrence. Biometrics 77 (3) (2020)
Yanyao Yi, Ting Ye, Menggang Yu, Jun Shao
Cox regression with survival-time-dependent missing covariate values. Biometrics 76 (2) (2019)
Jared D Huling, Menggang Yu, A James O'Malley
Instrumental variable based estimation under the semiparametric accelerated failure time model. Biometrics 75 (2) (2019)
Ting Ye, Menggang Yu
A robust approach to sample size calculation in cancer immunotherapy trials with delayed treatment effect. Biometrics 74 (4) (2018)
Zhilan Lou, Jun Shao, Menggang Yu
Optimal treatment assignment to maximize expected outcome with multiple treatments. Biometrics 74 (2) (2017)
Jared D Huling, Menggang Yu, Muxuan Liang, Maureen Smith
Risk prediction for heterogeneous populations with application to hospital admission prediction. Biometrics 74 (2) (2017)

Menggang Yu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Menggang Yu